Jason Throne - Mar 1, 2024 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Chief Legal Officer
Signature
/s/ Jason Throne
Stock symbol
IDYA
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/4/2024, 05:24 PM
Previous filing
Dec 19, 2023
Next filing
Jun 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +126K $0.00 126K Mar 1, 2024 Common Stock 126K $46.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Title: SVP, Head of Finance and Investor Relations